Simplify Logo

Full-Time

Research Scientist

Protein Mass Spectrometry

Updated on 9/19/2024

AbCellera Biologics

AbCellera Biologics

501-1,000 employees

Biotechnology firm specializing in antibody therapies

Biotechnology
Healthcare

Compensation Overview

$75.2k - $94kAnnually

+ Equity + Bonus + RRSP Contribution + Active Lifestyle Allowance + Vacation + Professional Development + Health Benefits

Senior, Expert

Vancouver, BC, Canada

Category
Lab & Research
Life Sciences
Requirements
  • demonstrated hands-on laboratory experience relevant to the characterization of antibodies and/or other therapeutic proteins using mass spectrometry and other analytical techniques
  • PhD in Biochemistry, Structural biology or related field, or MSc with 5+ years in an academic or industry wet lab environment with emphasis on mass spectrometry
  • demonstrated expertise in protein mass spectrometry analysis, including intact mass and peptide mapping assays for identifying and quantifying post translational modifications on antibodies
  • demonstrated experience in characterization of proteins using analytical chromatography, light scattering, thermal denaturation or other analytical or biophysical techniques
  • hands on experience with sample preparation for mass spectrometry analysis
  • great interpersonal skills with the ability to work collaboratively as a member of cross-functional team
  • self-motivated and have the initiative and drive to meet goals under tight project timelines
  • impeccable attention to detail, with the ability to analyze and interpret large datasets
Responsibilities
  • Designing, planning and executing experiments, either independently or in collaboration with your teammates
  • Performing mass spectrometry analysis of antibodies and other therapeutic proteins, including intact mass, peptide mapping, glycan profile, and other post-translational modification
  • Performing detailed protein structural interrogation, including sequence confirmation, sequence variant identification, disulfide mapping, or chemical modifications in support of batch comparison, forced degradation and developability analysis
  • Developing and performing analytical assays for protein characterization, including UPLC, light scattering, CE-SDS, cIEF
  • Training and mentoring members of a dynamic team
  • Solving problems at a high level
  • Liaising with partners and communicating project updates and deliverables
  • Developing and implementing standard operating procedures
  • Organizing, supporting, and collaborating with team members to meet project deliverables and timelines

AbCellera specializes in discovering and developing therapeutic antibodies for various diseases. The company uses a proprietary technology platform that combines different scientific methods to identify and create antibodies efficiently. Clients, including pharmaceutical companies and research institutions, partner with AbCellera to enhance their drug development processes. Unlike many competitors, AbCellera focuses on challenging targets that traditional methods struggle to address. The company aims to accelerate the development of new medicines through collaborations, generating revenue from discovery services, licensing agreements, and its own therapeutic programs.

Company Stage

Series A

Total Funding

$393.1M

Headquarters

Vancouver, Canada

Founded

2012

Growth & Insights
Headcount

6 month growth

4%

1 year growth

1%

2 year growth

35%
Simplify Jobs

Simplify's Take

What believers are saying

  • Strategic collaborations with firms like Viking Global Investors and Biogen expand AbCellera's capabilities and market opportunities.
  • AbCellera's participation in high-profile industry conferences and presentations, such as AACR, showcases its cutting-edge research and strengthens its industry reputation.
  • The company's internal pipeline of therapeutic programs offers potential for significant breakthroughs and new treatments.

What critics are saying

  • The highly competitive and rapidly evolving biopharmaceutical market requires continuous innovation to maintain a competitive edge.
  • The recent resignation of board member Peter Thiel could lead to strategic and governance challenges.

What makes AbCellera Biologics unique

  • AbCellera's proprietary technology platform accelerates antibody discovery, making it faster and more efficient than traditional methods.
  • The company's ability to tackle challenging targets that have been difficult to address with traditional methods sets it apart in the biopharmaceutical market.
  • AbCellera's collaborative business model, which includes partnerships with leading investment firms and biotech companies, enhances its innovation and market reach.